VOYA Investment Management
ADCT icon

VOYA Investment Management’s ADC Therapeutics ADCT Stock Holding History

VOYA Investment Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,395
Closed -$65.2K – 2486
2026
Q1 		$65.2K Buy
17,395
+3,020
+21% +$11.9K ﹤0.01% 2246
2025
Q4 		$50.7K Buy
14,375
+805
+6% +$3.27K ﹤0.01% 2340
2025
Q3 		$54.3K Sell
13,570
-8,341
-38% -$26.3K ﹤0.01% 2377
2025
Q2 		$58.7K Sell
21,911
-362
-2% -$761 ﹤0.01% 2574
2025
Q1 		$31.4K Sell
22,273
-1,513
-6% -$2.57K ﹤0.01% 2588
2024
Q4 		$47.3K Sell
23,786
-1,613
-6% -$4.22K ﹤0.01% 2690
2024
Q3 		$80K Buy
25,399
+1,279
+5% +$4.03K ﹤0.01% 2703
2024
Q2 		$76.2K Buy
+24,120
New +$95.9K ﹤0.01% 2734

Other funds holding ADCT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

VOYA Investment Management's ADCT Position: Q2 2026 in Review

VOYA Investment Management sold out of ADC Therapeutics (ADCT) in Q2 2026, closing a stake of 17,395 shares — an estimated $65.2K sold.

VOYA Investment Management first reported a position in ADCT in Q2 2024 and held it in 8 quarters. The position peaked at $80K in Q3 2024. 113 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

  • VOYA Investment Management reported no remaining ADC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • VOYA Investment Management sold 17,395 ADC Therapeutics shares in Q2 2026, an estimated $65.2K.
  • VOYA Investment Management first reported a position in ADC Therapeutics in Q2 2024 and held it in 8 quarters.
  • VOYA Investment Management's ADC Therapeutics position peaked at $80K in Q3 2024.
  • 113 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.